101
102
103
Li, N, van den Bergh, J P, Boonen, A, Wyers, C E, Bours, S P G, Hiligsmann, M
Veröffentlicht in: Li , N , van den Bergh , J P , Boonen , A , Wyers , C E , Bours , S P G & Hiligsmann , M 2024 , ' Cost-effectiveness analysis of fracture liaison services : a Markov model using Dutch real-world data ' , Osteoporosis International , vol. 35 , no. 2 , pp. 293–307 . https://doi.org/10.1007/s00198-023-06924-2;
2024
Veröffentlicht in: Li , N , van den Bergh , J P , Boonen , A , Wyers , C E , Bours , S P G & Hiligsmann , M 2024 , ' Cost-effectiveness analysis of fracture liaison services : a Markov model using Dutch real-world data ' , Osteoporosis International , vol. 35 , no. 2 , pp. 293–307 . https://doi.org/10.1007/s00198-023-06924-2;
2024
104
105
106
107
108
Krabbe-Alkemade, Yvonne, Groot, Tom, Boter, Jaap
Veröffentlicht in: Krabbe-Alkemade , Y , Groot , T & Boter , J 2019 , ' The impact of hospital competition and insurer concentration on health care volume and cost in Dutch hospitals ' , Maandblad voor accountancy en bedrijfseconomie , vol. 93 , no. 7/8 , 34164 , pp. 203-213 . https://doi.org/10.5117/mab.93.34164;
2019
Veröffentlicht in: Krabbe-Alkemade , Y , Groot , T & Boter , J 2019 , ' The impact of hospital competition and insurer concentration on health care volume and cost in Dutch hospitals ' , Maandblad voor accountancy en bedrijfseconomie , vol. 93 , no. 7/8 , 34164 , pp. 203-213 . https://doi.org/10.5117/mab.93.34164;
2019
109
Postma, Maarten J.
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
Veröffentlicht in: Postma , M J 2010 , ' Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands : Recent publication reinforces favorable cost-effectiveness despite misleading conclusion ' , Vaccine , vol. 28 , no. 4 , pp. 873-874 . https://doi.org/10.1016/j.vaccine.2009.10.109;
2010
110
Geurten, R.J., Elissen, A.M.J., Bilo, H.J.G., Struijs, J.N., van Tilburg, C., Ruwaard, D.
Veröffentlicht in: Geurten , R J , Elissen , A M J , Bilo , H J G , Struijs , J N , van Tilburg , C & Ruwaard , D 2021 , ' Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures ' , BMJ Open , vol. 11 , no. 12 , e049487 . https://doi.org/10.1136/bmjopen-2021-049487;
2021
Veröffentlicht in: Geurten , R J , Elissen , A M J , Bilo , H J G , Struijs , J N , van Tilburg , C & Ruwaard , D 2021 , ' Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures ' , BMJ Open , vol. 11 , no. 12 , e049487 . https://doi.org/10.1136/bmjopen-2021-049487;
2021